BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $360K of BioMarin Pharmaceutical Inc.
Sold$359,560
$89.89Price
4,000Shares
−1%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Fri, Oct 14. Filed Tue, Oct 18, 8:01 PM ET, after the close. Not investment advice.